@medtechmd

Photo: William Stewart Halsted : Father of modern surgery.

 Florida, USA
Joined July 2011
  • Tweets4.2K
  • Following96
  • Followers977
1.1KMedia
Brain Computer Interface: BCI making great strides: share.google/NXHxLexbvexSKQm…

Paradromics gets FDA nod to expand brain implant study recruitment

The Connexus trial can consider eligible participants nationwide after regulators removed a four-hour driving-distance requirement.

mobihealthnews.com
1
189
$ABT : Oncodetect MRD Test: share.google/RRfhH8mwYeQO0Wr…

Abbott launches MRD test with improved cancer detection tech

Dr. Rick Baehner, Abbott’s chief medical officer for precision oncology, spoke to MedTech Dive about how the new version of the Oncodetect test performs and the market it addresses.

medtechdive.com
1
185
$HTFL : Suing rival for patent infringement .share.google/0En31LgzyZh5dJ9…

Heartflow sues AI rival Elucid over alleged IP violations

Heartflow filed the lawsuit after Elucid received FDA clearance for its new AI-enabled FFR-CT software. Elucid, meanwhile, is standing behind its technology and plans on responding through the...

cardiovascularbusiness.com
1
217
Extraordinary market volatility: $HTFL another 52 week high. A new paradigm in diagnostic coronary angiography.
1
1
240
Wider insurance coverage for services such as $HTFL FFR-CT physiologic assessment and coronary plaque analysis is helping expand access to these technologies. $HTFL : Making diagnostic coronary angiography a thing of the past. share.google/WQCrflc4CkPLYod…

CCTA helping more and more cardiologists plan ahead before PCI

CCTA offers clinicians an opportunity to make patient care more efficient. However, interventionalists need to make sure they understand how to properly interpret coronary CT data.

cardiovascularbusiness.com
1
213
KIDNEY CARE NATIONAL PLAN : share.google/uZ9S05idqJgODSy… COULD BE BENEFICIAL FOR $TMDX $HUMA
2
2
7
909
$HTFL : “After analyzing the company's technology versus the competitors, the firm believes they have a strong moat that should keep them generating some of the best revenue growth in all of medical technology in the coming quarters and years.”
1
2
472
$RAPP :  “Based on these results, RAP-219 has the potential to become a mainstay of treatment for acute mania.” Impressive mid-stage results! share.google/d2FaXLGfKIjB9iO…

Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the...

The trial met the primary and secondary endpoints with statistically significant placebo-adjusted improvements at Week 3 in the YMRS total score (3.1 points; p=0.045) and CGI-BP Severity of Mania...

investors.rapportrx.com
1
1
3
1,603
French students frantically search Christian Dior for school uniforms after their school reportedly ran out of blazers ahead of parents evening
829
11,703
404
57,807
884,582
$TEVA : Sell side becoming more positive on the Teva turnaround.
226
$RAPP : Precision drug directed towards Focal Onset Seizures conducted with $NPCE RNS system to track treatment effect.
428
share.google/QSoXyTcCGIHLrUJ… $BX : Galderma (SIX : $GALD) Buys Blackstone Backed Aesthetics Company.
1
313
Martin Shkreli
1
262
$TMDX : Price target $94.00.
2
5
1,035
Excerpt from Jefferies report on the Diabetes space with regard to worldwide CGM market. $ABT Freestyle Libre still leads with a 55% market share over $DXCM at 34%.
1
1
397
$MBX : Awaiting Results From Once Monthly Dosing In Obesity Patients.
262
$TEVA : Numbers Go Up At Jefferies: $40.00 To $48.00, On Better Execution, Positive News Flow.
4
466
$FOCL : Utilizing Focal One HIFU to treat rectal endometriosis in the EU.
Focal One
@FocalOneHIFUOct 9
Great moments from the ESGE (@esge_news) Annual Meeting in Poland, bringing together physicians and experts from across Europe to exchange perspectives on the latest advances in endometriosis management and gynaecological endoscopy. We were proud to contribute to the conversation around minimally invasive treatment approaches, including the potential of @FocalOneHIFU in the management of deep rectal endometriosis. A special congratulations to Prof. Gil Dubernard on receiving the Best Oral Presentation Award for his presentation, “Long-term clinical results of High Intensity Focused Ultrasound treatment of rectal endometriosis.” This recognition highlights the quality of his work and the growing body of clinical evidence supporting focal therapy. Thank you to Medico Systems, Zibbi Zinkiewicz, and their team for their collaboration and support, and to the entire ESGE community for the meaningful scientific exchange. We look forward to continuing to advance innovative, non-invasive treatment options and improve care for patients living with endometriosis. #ESGE2026 | #Endometriosis | #RoboticSurgery | #MedTech | #HIFU
2
2
487
WELTRUZA™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous long-acting injectable (LAI) formulation of olanzapine for the treatment of schizophrenia in adults. Once monthly dosing a big advantage for patients: $TEVA
1
356
$ABT : Undervalued Healthcare Conglomerate.
2
366
Load more